← 返回

静脉、腹腔或瘤内注射 NK 细胞在人胰腺腺癌荷瘤小鼠中的急性毒性:随机研究

英文原题:Acute toxicities of intravenous, intraperitoneal, or intratumoral injection of natural killer cells in human pancreatic adenocarcinoma-bearing mice: Randomized study.

查看英文原题

Acute toxicities of intravenous, intraperitoneal, or intratumoral injection of natural killer cells in human pancreatic adenocarcinoma-bearing mice: Randomized study.

PubMed 2023/09/03(内容时间) Int Immunopharmacol Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

在我们的研究中,静脉注射似乎是将 NK 细胞给予携带 PaC 的人源化小鼠的最安全方式。采用腹腔内或瘤内给药时,脾、肝和肺是最常受累的器官,尽管大多为轻度病理改变。

研究思路结论见上方概要

目的:探讨经静脉、腹腔或瘤内注射NK细胞对皮下荷人胰腺腺癌(PaC)小鼠可能产生的急性毒性及病理学改变。

100只NPG荷瘤小鼠(50只/性别)在给药前9天皮下接种人PaC BXPC-3细胞。它们被随机分为10组,每组5只雄性和5只雌性。第1组小鼠静脉给予氯化钠作为溶媒对照,第2-4组小鼠分别静脉给予人外周血来源NK细胞,剂量为2 × 10 7、1 × 10 8和5 × 10 8 cells/kg;第5-7组小鼠分别腹腔注射NK细胞,剂量为2 × 10 7、1 × 10 8和5 × 10 8 cells/kg,第8-10组小鼠分别瘤内注射NK细胞,剂量为4 × 10 3、2 × 10 4和1 × 10 5 cells/mm 3。每组给予单次剂量;对小鼠进行临床观察,并测量体重、摄食量、血液生化和肿瘤体积。第15天,将小鼠安乐死进行大体解剖和组织病理学检查。

计划安乐死时,第2-4组未发现与细胞注射相关的肉眼或显微镜下病理改变;第5-7组中,雌雄小鼠均显示脾脏髓外造血减少,且在5 × 10 8 cells/kg剂量下,雌雄小鼠均显示脾脏白髓细胞组成增加。第8-10组中,雌雄小鼠在4 × 10 3和1 × 10 5 cells/mm 3剂量下以及雌性小鼠在2 × 10 4 cells/mm 3剂量下显示脾脏髓外造血减少,雌性小鼠在4 × 10 3 cells/mm 3剂量下以及雌雄小鼠在≥ 2 × 10 4 cells/mm 3剂量下显示脾脏白髓细胞组成增加;雌雄小鼠在≥ 2 × 10 4 cells/mm 3剂量下观察到肺和支气管血管周围/细支气管周围炎性细胞浸润,雌雄小鼠在1 × 10 5 cells/mm 3剂量下观察到肝脏炎性细胞浸润。各组在临床观察、体重、摄食量或血液生化方面均未观察到其他具有毒理学意义的异常变化。

展开英文摘要原文

100 NPG tumor-bearing mice (50/sex) were engrafted subcutaneously with human PaC BXPC-3 cells 9 days before administration. They were randomly divided into 10 groups with 5 males and 5 females in each group. Mice in Group 1 were given sodium chloride intravenously as vehicle control, and mice in Groups 2-4 human peripheral blood-derived NK cells intravenously at doses of 2 × 10 7 , 1 × 10 8 , and 5 × 10 8 cells/kg, respectively; mice in Groups 5-7 were injected with NK cells intraperitoneally at doses of 2 × 10 7 , 1 × 10 8 , and 5 × 10 8 cells/kg, respectively, and mice in Groups 8-10 with NK cells intratumorally at doses of 4 × 10 3 , 2 × 10 4 , and 1 × 10 5 cells/mm 3 , respectively. Each group was given a single dose; the mice were observed clinically, and body weight, food intake, blood biochemistry, and tumor volume were measured. On Day 15, the mice were euthanized for gross anatomy and histopathology.

On planned euthanasia, in Groups 2-4 no gross or microscopic pathological changes related to cells injection were found; in Groups 5-7 mice of both sexes showed a decrease in extramedullary hematopoiesis of spleen, and at the dose of 5 × 10 8 cells/kg, mice of both sexes showed an increase in the composition of spleen white pulp cells. In Groups 8-10, mice of both sexes at doses of 4 × 10 3 and 1 × 10 5 cells/mm 3 and female mice at the dose of 2 × 10 4 cells/mm 3 showed a decrease in extramedullary hematopoiesis of spleen, and female mice at a dose of 4 × 10 3 cells/mm 3 and mice of both sexes at doses of ≥ 2 × 10 4 cells/mm 3 showed an increase in the composition of spleen white pulp cells; perivascular/peribronchiolar inflammatory cell infiltration in lung and bronchus was observed in mice of both sexes at doses of ≥ 2 × 10 4 cells/mm 3 , and inflammatory cell infiltration in liver was observed in mice of both sexes at a dose of 1 × 10 5 cells/mm 3 . No other abnormal changes with toxicological significance in clinical observation, body weight, food intake, or blood biochemistry were observed in each group.

In our study intravenous injection appears the safest way to give NK cells to human PaC-bearing mice. Using intraperitoneal or intratumoral administration, spleen, liver, and lung were the most often affected organs, albeit with mostly mild pathological changes.

论文信息

作者
Huang L、Lyu Z、Yang H、Gu M、Jiao Y、Shi Y
第一作者单位
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Medical Center on Aging of Ruijin Hospital, MCARJH, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: lei.huang@alumni.dkfz.de.China
通讯作者单位
Department of General Surgery, Shanghai Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: sy_rjh@aliyun.com.China
期刊
International immunopharmacology2023 Nov
原文标识
PubMed 37666066 · DOI 10.1016/j.intimp.2023.110881